Edition:
India

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

18.40USD
20 May 2019
Change (% chg)

$-0.34 (-1.81%)
Prev Close
$18.74
Open
$18.55
Day's High
$18.60
Day's Low
$18.29
Volume
11,965
Avg. Vol
205,475
52-wk High
$20.00
52-wk Low
$8.64

About

Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. The Company's cell therapy pipeline consists of immuno-oncology programs, including cancer immunotherapies derived from... (more)

Overall

Beta: 1.88
Market Cap(Mil.): $1,221.58
Shares Outstanding(Mil.): 65.19
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates